Takeaway

• Diltiazem treatment for 6 weeks failed to improve coronary vasomotor dysfunction, angina symptoms, and quality of life (QoL) but reduced the prevalence of epicardial spasm in patients with angina and no obstructive coronary artery disease (ANOCA).

Why this matters

• Around four in 10 patients undergoing coronary angiography for stable angina are...